The Otto Aufranc Award Identification of a 4 Mb Region on Chromosome 17q21 Linked to Developmental Dysplasia of the Hip in One 18-member, Multigeneration Family by Feldman, George et al.
Thomas Jefferson University
Jefferson Digital Commons
Department of Orthopaedic Surgery Faculty Papers Department of Orthopaedic Surgery
9-15-2009
The Otto Aufranc Award Identification of a 4 Mb
Region on Chromosome 17q21 Linked to
Developmental Dysplasia of the Hip in One
18-member, Multigeneration Family
George Feldman
Thomas Jefferson University and the Rothman Institute of Orthopaedics, gfel640946@aol.com
Chelsea Dalsey
Thomas Jefferson University and the Rothman Institute of Orthopaedics
Kasia Fertala
Thomas Jefferson University and the Rothman Institute of Orthopaedics
David Azimi
Thomas Jefferson University and the Rothman Institute of Orthopaedics
Paolo Fortina
Department of Cancer Biology, Kimmel Cancer Center, Thomas Jefferson University
See next page for additional authorsLet us know how access to this document benefits you
Follow this and additional works at: http://jdc.jefferson.edu/orthofp
Part of the Medical Genetics Commons, and the Orthopedics Commons
This Article is brought to you for free and open access by the Jefferson Digital Commons. The Jefferson Digital Commons is a service of Thomas
Jefferson University's Center for Teaching and Learning (CTL). The Commons is a showcase for Jefferson books and journals, peer-reviewed scholarly
publications, unique historical collections from the University archives, and teaching tools. The Jefferson Digital Commons allows researchers and
interested readers anywhere in the world to learn about and keep up to date with Jefferson scholarship. This article has been accepted for inclusion in
Department of Orthopaedic Surgery Faculty Papers by an authorized administrator of the Jefferson Digital Commons. For more information, please
contact: JeffersonDigitalCommons@jefferson.edu.
Recommended Citation
Feldman, George; Dalsey, Chelsea; Fertala, Kasia; Azimi, David; Fortina, Paolo; Devoto, Marcella;
Pacifici, Maurizio; and Parvizi, Javad, "The Otto Aufranc Award Identification of a 4 Mb Region on
Chromosome 17q21 Linked to Developmental Dysplasia of the Hip in One 18-member,
Multigeneration Family" (2009). Department of Orthopaedic Surgery Faculty Papers. Paper 21.
http://jdc.jefferson.edu/orthofp/21
Authors
George Feldman, Chelsea Dalsey, Kasia Fertala, David Azimi, Paolo Fortina, Marcella Devoto, Maurizio
Pacifici, and Javad Parvizi
This article is available at Jefferson Digital Commons: http://jdc.jefferson.edu/orthofp/21
The Otto Aufranc Award 1 
Identification of a 4 Mb Region on Chromosome 17q21 Linked to Developmental Dysplasia 2 
of the Hip in One 18-member, Multigeneration Family 3 
 4 
George Feldman PhD, DMD 5 
Chelsea Dalsey BA 6 
Kasia Fertala BA 7 
David Azimi BS 8 
Paolo Fortina MD 9 
Marcella Devoto PhD 10 
Maurizio Pacifici PhD 11 
Javad Parvizi MD, FRCS. 12 
 13 
Investigations were performed at Thomas Jefferson University and the  14 
Rothman Institute of Orthopaedics 15 
 16 
 17 
 18 
Disclosure of Interest Statement: No funding was received in support of this study. 19 
 20 
 21 
Word count:  22 
 23 
Correspondence to: 24 
Javad Parvizi MD, FRCS 25 
925 Chestnut Street 5th floor 26 
Philadelphia, PA 19107 27 
Email: parvj@aol.com 28 
Fax: 215 503 0580 29 
Telephone: 267 3393645 30 
Abstract 31 
Developmental dysplasia of the hip (DDH) is a disabling condition of the hip that, 32 
depending on geography, can afflict between 20-80% of patients with end-stage arthritis of the 33 
hip. Despite its prevalence, the etiology of this disease remains unknown. DDH is a complex 34 
disorder with both environmental and genetic causes.. Based on the literature, the candidate genes 35 
for the disease are HOXB9, collagen type I α1, and DLX 3. The purpose of our study was to map 36 
and characterize the gene or genes responsible for this disorder by family linkage analysis. We 37 
recruited one 18-member, multigeneration affected family to provide cheek swabs and blood 38 
samples for isolation of DNA. Amplified DNA underwent a total genome scan using GeneChip 39 
Mapping 250 K Assay (Affymetrix, Santa Clara, CA). We observed only one region with a LOD 40 
score greater than 1.5: a 4Mb region on chromosome 17q21.32, yielding a LOD score of 1.82. 41 
While a LOD score of 1.82 does not meet the accepted standard for linkage we interpret these 42 
data as suggesting the responsible gene could be linked to this region, which includes a cluster of 43 
homeobox regulatory system providing cells with specific positional identities along the 44 
developing joint and spine. Discovering the genetic basis of the disease would be an important 45 
step in understanding the etiology of the disabling condition. 46 
Introduction 47 
Developmental dysplasia of the hip, previously known as congenital dislocation of the hip, 48 
is a frequently disabling condition characterized by incomplete formation of the acetabulum 49 
and/or femur leading to frequent subluxation or dislocation of the hip, suboptimal joint function, 50 
and accelerated wear of the articular cartilage resulting in arthritis. This condition affects one in 51 
1000 newborn infants in the United States  [34].  The prevalence of the disease is even higher in 52 
some parts of the world such as Japan, Italy and other Mediterranean countries [28].  Because of 53 
its high prevalence and the undesirable consequences, a screening program is in place in nearly 54 
every country that involves clinical examination of the hip of the newborn [29].  Although 55 
relatively accurate for detecting gross dislocation or dislocatable hips, the examination cannot 56 
detect milder degrees of hip dysplasia [35].  In fact, the dynamic nature of the condition prompted 57 
experts to change its name from the traditional “congential dislocation of the hip” to 58 
“developmental dysplasia of the hip.” The reason behind this change two decades ago was two-59 
fold. First, the pathology of the disorder varies per patient and does not consistently result in 60 
complete dislocation, but instead in subluxation or dyplasia. Second, should any form of the 61 
condition occur, it often happens postnatally and therefore cannot be termed truly congenital [16]. 62 
Moreover, many patients affected by the condition do not discover their diagnosis until later years 63 
of life when arthritis of the hip is instigated [23]. Over the past 20 years, “developmental 64 
dysplasia” has become more widely preferred than the misleading “congenital dislocation,” 65 
encompassing a wider spectrum of form of the condition than earlier [2, 16]. Developmental 66 
dysplasia of the hip (DDH) is therefore a complex disorder with both environmental [29] and 67 
genetic causes. 68 
Although DDH presents with varying intensity in affected individuals, as determined by 69 
the degree of femoral head undercoverage, it also may often affect members of a single family 70 
[31]. Based on its pattern of presentation in families, the condition is believed to have a strong 71 
genetic basis [35]. Genome-wide scans of large affected families have yielded linkage to 72 
chromosomes 4q35, 13q22, and 16p, but no gene mutations in these regions have been found [17, 73 
19]. Linkage to chromosome 12q13, where the collagen type 2- α1 and vitamin D receptor are 74 
located, was recently excluded as were two polymorphic sites within the COL1A1 gene [28]. A 75 
recent genetic association study of 335 affected and 622 control individuals found an association 76 
of a GDF5 single nucleotide polymorphism (SNP) with DDH [5] (Table 1). Developmental 77 
dysplasia of the hip is also seen among dogs, affecting some pedigrees much more commonly. 78 
Based on linkage studies in large canine pedigree studies, veterinary researchers have proposed a 79 
genetic basis for the disease and have made substantial progress in mapping this disorder [21, 30]. 80 
Although no mutations in canine genes have been definitely linked to DDH various genetic loci in 81 
large canine pedigrees have been linked to DDH.  82 
The familial inheritance patterns and a higher concordance rate between identical twins 83 
(41.4%) compared with that between fraternal twins (2.8%) strongly support genetic transmission 84 
among humans [34, 35]. There is another reason to believe that a single-gene or multiple-gene 85 
mutation may be implicated in this condition. Developmental dysplasia of the hip can be 86 
associated with other conditions such as clubfoot, renal malformations, and cardiac anomalies 87 
[13]. In fact, DDH is not uncommonly part of a syndrome affecting multiple systems in the body 88 
[13]. A majority of the patients with DDH, however, have an isolated condition with unilateral or 89 
bilateral hip disease.  90 
  Based on the strong evidence of a genetic contribution to the etiology of DDH, we 91 
wondered, without making any assumptions about where potentially causative mutations reside, 92 
whether we could identify a genetic haplotype that was uniquely shared by all affected members 93 
and not present in unaffected members of the family in this study, elucidating the etiology of their 94 
disorder. 95 
 96 
Patients and Methods 97 
Our institutional prospective database on joint arthroplasty was used to identify patients 98 
with DDH. Initially, our electronic database of over 22,000 patients undergoing hip arthroplasty 99 
was scanned to identify patients with DDH (International Classification of Diseases, 9th Revision 100 
[ICD-9] codes 745.30 and 755.63). We identified 234 patients. We believed some patients with 101 
DDH undergoing THA might have been coded under end-stage arthritis (ICD-9 code 715.15). 102 
Relying on the notion that most patients with DDH require THA at a younger age, as the next 103 
step, we identified all patients younger than age 45 in the database institution. This resulted in the 104 
identification of an additional 2450 patients. The radiographs of all 2684 patients were then 105 
reviewed and appropriate measurements made to confirm or refute the diagnosis of DDH. After 106 
radiographic review, 435 of the approximately 22,000 patients (or about 2%) were believed to 107 
have DDH. All of these patients were contacted and asked to return for followup to obtain blood 108 
samples and/or buccal swabs for analysis. To date, 130 patients from 28 families have returned 109 
and donated DNA samples. At the time of this writing, the analysis had been completed in one 110 
18-member, multigeneration family whose proband is severely affected with DDH. All 18 family 111 
members consented to study participation and were evaluated both clinically and radiographically 112 
by the senior author (JP). Before the initiation of this study, Institutional Review Board approval 113 
was obtained.  114 
All consenting individuals had an anteroposterior and a cross-leg lateral radiograph of the 115 
hip performed as a routine. Other radiographs such as the faux profile to assess anterior coverage 116 
or abduction views to assess joint congruity were also performed in patients with DDH 117 
contemplating joint preservation surgery. Radiographs for each subject were measured by one of 118 
four experienced orthopaedic surgeons with the senior author (JP) confirming measurements for 119 
each subject. Analog radiographs were measured manually using an electronic goniometer, and 120 
digital radiographs were measured using software with an incorporated angle measurement 121 
system. Radiographic diagnosis of dysplasia was made based on standard definition [8, 24, 25]. 122 
Individuals were deemed to have DDH if one or more of the following was present: (1) Tönnis 123 
angle greater than 10º and/or (2) center-edge angle less than 20º [6]. Other measurements 124 
included the extrusion index, extent of lateral and superior migration of the femoral head, femoral 125 
neck angle, and posterior and anterior acetabular coverage (Table 2) [26]. The diagnosis of DDH 126 
was based on these parameters. Patient 001 was the proband in this study. This patient had a hip 127 
replaced because of DDH. The preoperative radiographs demonstrated severe arthritis that 128 
prevented us from making some of the measurements accurately. Individuals with acetabular 129 
retroversion and abnormal extrusion indices that differed from the norm by one standard deviation 130 
(Table 3) were categorized as “possible” dysplasia for the purpose of statistical analysis. No 131 
family members had been diagnosed with DDH at birth, but rather were diagnosed later in life.  132 
Cheek swab or serum DNA gathered from family members was isolated using the 133 
QIAamp DNA Blood Mini Kit and amplified using the REPLI-g Mini Kit (Qiagen, Valencia, CA) 134 
according to protocol. Amplified DNA was then processed according to the GeneChip Mapping 135 
250 K Assay Kit as recommended by the manufacturer (Affymetrix, Santa Clara, CA). Briefly, 136 
after Nsp I digestion, fragmented DNA was ligated to adaptor followed by PCR amplification. 137 
The PCR product was hybridized to the GeneChip Mapping 250 K Nsp Array and processed with 138 
the Fluidics Station and the GeneChip Scanner 3000 (Affymetrix). To eliminate uninformative 139 
markers and spurious calls, the following filters were applied to the data set. SNPs were selected 140 
for analysis that (1) generated calls for each family member; (2) had confidence scores less than 141 
0.3 (confidence scores are inversely related to reliability); (3) were polymorphic with a minor 142 
allele frequency of 0.2 or more; and (4) did not generate inheritance errors. This filtering process 143 
brought the original 262,314 SNPs down to 6840.  144 
Model-based and model-free multipoint LOD score analysis was performed using the 145 
software MERLIN Version 1.1.2 (www.sph.umich.edu/csg/abecasis/Merlin/). In the model-based 146 
analysis, to account for the diagnostic uncertainty in DDH, we divided individuals into two 147 
liability classes with different genetic penetrances (Table 4). Multipoint model-based LOD score 148 
analysis over the entire human genome, excluding the sex chromosomes, was performed.  149 
Penetrance is the probability of a given individual to be affected given that he or she 150 
carries zero, one, or two copies of the disease allele. Liability Class 1 contains individuals with 151 
three or more radiographic signs of DDH (1, 9, and 11). We have assigned a 0% probability of 152 
affection to individuals in this liability class if they have two normal alleles, and conservatively, 153 
we have assigned an 80% penetrance to carriers of one or two mutated alleles. Liability Class 2 154 
contains individuals with one of two radiographic signs of DDH (4, 5, 6, 8, 13, and 14). 155 
Individuals in this class who happen to be carriers of the mutated allele (either homozygotes or 156 
heterozygotes) have the same probability of being affected of 0.8. If an individual has no mutated 157 
allele, we assume a probability of affection equal to the incidence of the disorder in the overall 158 
population, one per 1000 live births, or 0.001.  159 
The analysis conducted assumes autosomal-dominant transmission of the affected allele. 160 
We reanalyzed the family using model-free analysis that makes no assumptions about the mode of 161 
transmission of this disorder. Individuals with any sign of DDH were included in this analysis (1, 162 
4, 5, 6, 8, 9, 11, 13, and 14). Results of this analysis produced a linked region on chromosome 17 163 
identical to that found by the model-based analysis using two liability classes as mentioned but 164 
with a lower maximum LOD score (data not shown).  165 
 166 
 167 
 168 
 169 
Results 170 
 171 
Based on the data in one family of 18 members in three generations, the DDH phenotype 172 
had an autosomal-dominant transmission (Fig. 1). X-linked inheritance was ruled out based on 173 
male-to-male transmission of the disease in this pedigree. The maximum multipoint LOD score 174 
(1.82) occurred at SNP rs16949053, located 45,844,439 base pairs from the p-term of 175 
chromosome 17, with a score of 1.82 (Fig.2A). The region of positive LOD score extended from 176 
rs2597165 to rs996379 for approximately 4 Mb.  177 
The second largest LOD score, oh chromosome 16, was 1.38 at rs11866385 at position 178 
10,016,159. However, the two flanking markers both had negative LOD scores, thus limiting the 179 
positive LOD score region to a very small interval of approximately 470 Kb. No other genomic 180 
region yielded LOD scores greater than 0.5. 181 
 182 
Discussion 183 
The focus of our study is to map and characterize the gene or genes responsible for this 184 
disorder by family linkage analysis. We therefore asked whether we could find a genetic 185 
haplotype that was uniquely shared by all affected members and not present in unaffected 186 
members of the family in this study, elucidating the etiology of their disorder.  187 
Important limitations to this study include both the relatively small family size as well as 188 
the diagnostic uncertainty, both of which limit statistical power. A LOD score of 1.82 does not 189 
meet the accepted standard for linkage. Therefore, these findings should be viewed conditionally. 190 
As elaborated subsequently, the value of our study is that it provides supportive evidence for the 191 
biologic importance of this candidate region found to be significant in canine studies and in 192 
studies by other investigators studying DDH-affected families in China.  193 
The linkage analysis of one multigeneration affected family in this study has demonstrated 194 
that DDH does indeed show genetic inheritance with an autosomal-dominant mode of 195 
transmission. Furthermore, the mutated gene for the condition appears linked to a region 4Mb in 196 
size on chromosome 17q21. The fact that a genome scan of all human chromosomes produces just 197 
one plausible candidate region adds credence to the notion that a DDH-causing number of 198 
attractive candidate genes in this region (Fig. 2B). These genes were chosen among all genes 199 
(approximately 70 genes; see Fog 2B) within the chromosome 17q21 region defined by our data 200 
on the basis of whether their known function might explain the biologic origins of DDH. The 201 
entire HOXB cluster of homeobox genes is contained in the proximal end of this region. The 202 
HOXB cluster encodes genes that are part of the developmental regulatory system that provides 203 
cells with specific positional identities along the developing spine. One gene in particular, 204 
HOXB9, is expressed in human embryo from 5 to 9 weeks, a period that coincides with primordial 205 
temporal expression, it is expressed in the lubar, sacral, and caudal regions of the forming 206 
provertebra during this time [15]. PAX1, another transcription factor responsible for the 207 
development of the hip girdle in the chicken, is known to interact with several members of the 208 
HOX gene family [20]. 209 
Other attractive candidates in this region include collagen type I-αi (COL1A1) and DLX3 210 
(Distal-less homeobox 3). A polymorphism in the collagen type I-α1 gene might influence hip 211 
development [11]. Bone fragility and in its more severe forms, blue sclera and short stature, 212 
characterize various forms of osteogenesis imperfecta that are the result of mutations in te major 213 
component of connective tissue [3]. Other mutations in COL1A1 result in Ehlers-Danlos 214 
syndrome characterized by laxity of the skin and joints. Still other polymorphisms in the first 215 
intron of COL1A1 are correlated to bone mass and osteoporotic fracture [32].  216 
Although polymorphisms in the PCOL2 and Sp1 transcription factor binding sites of the 217 
COL1A1 gene do not appear associated with DDH in the Chinese population, COL1A1 mRNA 218 
and protein expression in the hip capsule of DDH-affected children was reportedly decreased 219 
compared with age- and gender-matched controls [11, 33]. These observations suggest that 220 
polymorphisms other than PCOL2 and Sp1 may be influencing COL1A1 expression in these 221 
affected individuals. DLX3 is a member of a family of transcription factors, including Runx2, that 222 
regulate the expression of osteocalcin during fetal mouse development [9]. 223 
Our findings help confirm those of Jiang et al. In 2003 who found after analyzing 101 224 
members of Chinese families, that the DDH locus was associated with a marker (D17S1820) that 225 
is included in our chromosome 17 candidate region [12]. Additional support for the biologic 226 
importance of this region in the etiology of DDH comes from recent studies of Marschall and 227 
Distl, in which a quantitative trait locus for hip dysplasia on canine chromosome 9 is syntenic to 228 
chromosome 17q21 on the human genome where our candidate gene locus resides [21]. In 229 
addition to analyzing the results of a second multigenerational family, we are in the process of 230 
sequencing one of a number of these candidate genes. 231 
In a small pilot genetic association study, Rouault and coinvestigators recently found no 232 
association of DDH with HOXB9 and COL1A1 in a small regional French population in which the 233 
incidence of this disorder was elevated [27]. Although an intriguing preliminary observation, the 234 
limited geographic sampling of this study does not preclude either of the genes playing a 235 
causative role in other populations. It is highly probable that DDH is genetically heterogeneous 236 
because hip formation involves the activation of numerous genes during development. Indeed, 237 
similar contradictory results have surfaced in the past that can be explained by population 238 
differences or small sample size and limited statistical power to detect genetic association. 239 
Recently, a polymorphism in the Calmodulin (CALM) promoter in associated with hip 240 
osteoarthritis in the Japanese population and decreases transcription of the gene in vitro and in 241 
vivo [22]. In a subsequent study, the CALM promoter polymorphism was excluded in a UK white 242 
population [18].  243 
Our data suggest the presence of a disease-associated mutation/polymorphism in a region 244 
of chromosome 17q21 in the affected members of the family in this study. Because our finding, 245 
that of Jiang et a;. [12] in the Chinese population, and those of the investigators studying the 246 
canine hip dysplasia [21] coincide, it is possible to hypothesize that mutations in candidate genes 247 
in this region could play a more prevalent role in causing susceptibility to this disorder. 248 
We have chosen to compensate for the diagnostic uncertainty of DDH in this study by 249 
using reduced penetrance and creating liability classes. Penetrance is the proportion of individuals 250 
with a mutation causing a particular disorder who exhibit clinical symptoms of that disorder. The 251 
use of liability classes in this study allows for the retention of the statistical power generated by 252 
our severely affected family members [1, 9, 11] but still accounts for the diagnostic uncertainty of 253 
other possibly affected members.  254 
We identified a single genetic locus linked to DDH in one multigeneration North 255 
American family. Our evidence suggests this locus is on human chromosome 17q21. We have 256 
identified a few potential candidate genes and are actively searching for mutations in a number of 257 
them by automated DNA sequence analysis. Identification of mutations or susceptibility-inducing 258 
polymorphisms in asymptomatic individuals with DDH might allow implementation of 259 
appropriate care in the future. 260 
  261 
 262 
 263 
Reference List 264 
 265 
 1.  Anonymous. HXB9_HUMAN UniProtKB Swiss. Available at: 266 
http://www.uniprot.org/uniprot/P17482#section_comments.  Accessed July 1, 2009.   267 
 2.  Brand RA. 50 years ago in CORR: congenital dislocation of the hip--its causes and effects. 268 
Clin Orthop Relat Res. 2008;466:1015-1016. 269 
   3.   Byers PH, Steiner RD. Osteogenesis imperfecta. Annu Rev Med. 1992;43:269-282.  270 
 4.  Cilliers HJ, Beighton P. Beukes familial hip dysplasia: an autosomal dominant entity. Am J 271 
Med Genet. 1990;36:386-390.  272 
 5.  Dai J, Shi D, Zhu P, Qin J, Ni H, Xu Y, Yao C, Zhu L, Zhu H, Zhao B, Wei J, Liu B, 273 
Ikegawa S, Jiang Q, Ding Y. Association of a single nucleotide polymorphism in growth 274 
differentiate factor 5 with congenital dysplasia of the hip: a case-control study. Arthritis Res 275 
Ther. 2008;10:R126. 276 
 6.  Delaunay S, Dussault RG, Kaplan PA, Alford BA. Radiographic measurements of 277 
dysplastic adult hips. Skeletal Radiol. 1997;26:75-81. 278 
 7.  Granchi D, Stea S, Sudanese A, Toni A, Baldini N, Giunti A. Association of two gene 279 
polymorphisms with osteoarthritis secondary to hip dysplasia. Clin Orthop Relat Res. 280 
2002;403:108-117.  281 
 8.  Harris WH. Etiology of osteoarthritis of the hip. clin Orthop Relat Res. 1986;213:20-33. 282 
 9.  Hassan MQ, Javed A, Morasso MI, Karlin J., Montecino M, van Wijnen AJ, Stein GS, Stein 283 
JL, Lian JB. Dlx3 transcriptional regulation of osteoblast differentiation: temporal 284 
recruitment of Msx2, Dlx3, and Dlx homeodomain proteins to chromatin of the osteocalcin 285 
gene. Mol Cell Biol. 2004;24:9248-9261. 286 
 10.  Ingvarsson T, Stefansson SE, Gulcher JR, Jonsdottir T, Walters GB, Lohmander LS, 287 
Stefansson K. A large Icelandic family with early osteoarthritis of the hip associated with a 288 
susceptibility locus on chromosome 16p. Arthritis Rheum. 2001;44:2548-2555.  289 
 11.  Jiang J, Ma HW, Li QW, Lu JF, Niu GH, Zhang LJ, Ji SJ. Association analysis on the 290 
polymorphisms of PCOL2 and Sp1 binding sites of COL1A1 gene and the congenital 291 
dislocation of the him in Chinese populations [in Chinese]. Zhonghua Yi Xue Yi Chuan Xue 292 
Za Zhi. 2005;22:327-329.  293 
 12.  Jiang J, Ma HW, Lu Y, Wang YP, Wang Y, Li QW, Ji SJ. Transmission disequilibrium test 294 
for congenital dislocation of the hip and HOXB9 gene or COL1AI gene [in Chinese]. 295 
Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2003;20:193-195. 296 
 13.  Karapinar L, Surenkok F, Ozturk H,Us MR, Yurdakul L. The importance of predicted risk 297 
factors in developmental hip dysplasia: an ultrasonographic screening program [in Turkish]. 298 
Acta Orthop Traumatol Turc. 2002;36:106-110.  299 
 14.  Kent WJ, Sugnet CW, Furey TS, Roskin KM, Pringle TH, Zahler AM, Haussler D. The 300 
human genome browser at UCSC. Genome Res. 2002;12:996-1006.  301 
 15.  Kessel M. Respecification of vertebral identities by retinoic acid. Development. 1992; 302 
115:487-501.  303 
 16.  Klisic PJ. Congenital dislocation of the hip--a misleading term:brief report. j Bone Joint 304 
Surg Br. 1989;71:136..  305 
 17.  Loughlin J, Mustafa Z, Irven C, Smith A, Carr AJ, Sykes B, Chapman K. Stratification 306 
analysis of an osteoarthritis genome screen-suggestive linkage to chromosomes 4, 6, and 16. 307 
Am J Hum Genet. 1999;65:1795-1798. 308 
 309 
18.  Loughlin J, Sinsheimer JS, Carr A, Chapman K. The CALM1 core promoter polymorphism 310 
is not associated with hip osteoarthritis in a United Kingdom Caucasian population. 311 
Osteoarthritis Cartilage. 2006;14:295-298.  312 
 313 
19.  Mabuchi A, Nakamura S, Takatori Y, Ikegawa S. Familial osteoarthritis of the hip joint 314 
associated with acetabular dysplasia maps to chromosome 13q. Am J Hum Genet. 315 
2006;79:163-168.  316 
 317 
20.  Malashichev Y, Borkhvardt V, Christ B, Scaal M. Differential regulation of avian pelvic 318 
girdle development by the limb field extoderm. Anat Embryol (Berl). 2005; 210:187-197. 319 
 320 
21.  Marschall Y, Distl O. Mapping quantitative trait loci for canine hip dysplasia in German 321 
Shepherd dogs. Mamm Genome. 2007; 18:861-870.  322 
 323 
22.  Mototani H, Mabuchi A, Saito S, Fujioka M, Iida A, Takatori Y, Kotani A, Kubo T, 324 
Nakamura K, Sekine A, Murakami Y, Tsunoda T, Notoya K, Nakamura Y, Ikegawa S. A 325 
functional single nucleotide polymorphism in the core promoter region of CALM1 is 326 
associated with hip osteoarthritis in Japanese. Hum Mol Genet. 2005;14:1009-1017. 327 
 328 
23.  Murphy SB, Ganz R, Muller ME. The prognosis in untreated dysplasia of the hip. A study 329 
of radiographic factors that predict the outcome. J Bone Joint Surg Am. 1995;77:985-989. 330 
 331 
24.  Murphy SB, Kijewski PK, Millis MB, Harless A. Acetabular dysplasia in the adolescent and 332 
young adult. Clin Orthop Relat Res. 1990;261:214-223. 333 
 334 
25.  Nelitz M, Guenther KP, Gunkel S, Puhl W. Reliability of radiological measurements in the 335 
assessment of hip dysplasia in adults. Br J Radiol. 1999;72:331-334. 336 
 337 
26.  Reynolds D, Lucas J, Klaue K. Retroversion of the acetabulum. A cause of hip pain. J Bone 338 
Joint Surg Br. 1999;81:281-288. 339 
 340 
27.  Rouault K, Scotet V, Autret S, Gaucher F, Dubrana F, Tanguy D, Yaacoub El Rassi C, 341 
Fenoll B, Ferec C. Do HOXB9 and COL1A1 genes play a role in congenital dislocation of 342 
the hip? Study in a Caucasian population. Osteoarthritis Cartilage. 2009;17:1099-1105. 343 
 344 
28.  Rubini M, Cavallaro A, Calzolari E, Bighetti G, Sollazzo V. Exclusion of COL2A1 and 345 
VDR as developmental dysplasia of the hip genes. Clin Orthop Relat Res. 2008;466:878-346 
883. 347 
 348 
29.  Stein-Zamir C, Volovik I, Rispon S, Sabi R. Developmental dysplasia of the hip: risk 349 
markers, clinical screening and outcome. Pediatr Int. 2008;50:341-345. 350 
 351 
30.  Todhunter RJ, Bliss SP, Casella G, Wu R, Lust G, Burton-Wurster NI, Williams AJ, Gilbert 352 
RO, Acland GM. Genetic structure of susceptibility traits for hip dysplasia and 353 
microsatellite informativeness of an outcrossed canine pedigree. J Hered. 2003;94:39-48. 354 
 355 
31.  Tonnis D, Heinecke A. Acetabular and femoral anteversion: relationship with osteoarthritis 356 
of the hip. J Bone Joint Surg Am. 1999;81:1747-1770. 357 
 358 
32.  Uitterlinden AG, Burger H, Huang Q, Yue F, McGuigan FE, Grant SF, Hofman A, van 359 
Leeuwen JP, Pols HA, Palston SH. Relation of alleles of the collagen type Ialpha 1 gene to 360 
bone density and the risk of osteoporotic fractures in postmenopausal women. N Engl J 361 
Med. 1998;338:1016-1021. 362 
 363 
33.  Wang EBm Zhao Q, Li LY, Shi LW, Gao H. Expresson of COL1a1 and COL3a1 in the 364 
capsule of children with developmental dislocation of the hip [in Chinese]. Zhongguo Dang 365 
Dai Er Ke Za Zhi. 2008;10:493-496. 366 
 367 
34.  Weinstein SL. Natural history of congenital hip dislocation (CHD) and hip dysplasia. Clin 368 
Orthop Relat Res. 1987;225:62-76. 369 
 370 
35.  Wilkinson JA. Etiologic factors in congenital displacement of the hip and myelodysplasia. 371 
Clin Orthop Relat Res. 1992;281:75-83. 372 
 373 
 374 
 375 
 376 
 377 
 378 
Figure 1: This pedigree illustrates one large family showing transmission of the disease through 379 
three generations.  Symbols are explained in figure key. 380 
 381 
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*     =   DNA samples retrieved 
     =   unaffected female 
     =   unaffected male 
     =   female partially affected, 1-2 radiographic signs  
     =   male partially affected, 1-2 radiographic signs 
     =   affected female, >2 radiographic signs 
     =   affected male, >2 radiographic signs 
 
Figure 2A: This graph shows multipoint parametric analysis of the human chromosome 17. The 417 
maximum LOD score is 1.8221 at SNP rs16949053 located 45,844,439 base pairs from p-term of 418 
chromosome 17.  419 
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Figure 2B: This figure shows an ideogram of chromosome 17 with the box depicting the 440 
approximate location of the candidate region. Below this is an enlarged view of the 4.0-MB 441 
candidate region showing the position of the 73 transcripts contained in the region [14]. Reprinted 442 
with permission from http://genome.ucsc.edu/cite.html. 443 
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 453 
Table 1:  
Table 1.  Summary of findings of genetic studies of nonsyndromic DDH and early-onset hip osteoarthritis 
 
Author (year) Type of study Conclusion 
 
Rouault et al. (2009) [ 27] Pilot candidate locus association study 
 
Dai et al. (2008) [ 5] Candidate locus association study 
 
of 335 CDH subjects, 622 control 
 
subjects with candidate region 
 
Rubini et al. (2008) [ 28] Linkage exclusion 
 
Mabuchi and Nakamura (2006) [ 19]     Whole genome linkage 
 
Loughlin et al. (2006) [ 18] Candidate locus association study 
 
Jiang et al. (2005) [ 11] Linkage exclusion 
 
Mototani et al. (2005) [ 22] Candidate locus association study 
 
 
Jiang et al. (2003) [ 12] Candidate locus linkage study 
 
 
Granchi et al. (2002) [ 7] Candidate locus association study 
 
 
Ingvarrson et al. (2001) [ 10] Whole genome linkage study of large 
 
Icelandic family 
 
Cilliers and Beighton (1990) [ 4] Whole genome linkage of large 
 
Africaaner family 
 
 
HOXB9 and COL1A1 association with DDH not supported 
in study of small regional French population 
 
Significant association of GDF5 SNP with CDH 
 
 
COL2A1 and vitamin D receptor excluded from linkage to 
DDH 
 
DDH in one large Japanese family linked to chromosome 13q 
 
Calmodulin promoter polymorphism not associated with DDH 
in UK white population 
 
Two polymorphic sites within the COL1A1 gene found 
not to be linked to DDH in 81 small Chinese families 
 
A functional polymorphic SNP in promoter of the Calmodulin 
gene found to be associated with hip osteoarthritis 
 
in Japanese population 
 
Association of one allele of one microsatellite marker 
(D17S1820) on chromosome 17q21 with CDH phenotype 
in 101 Chinese families 
 
Pilot study suggests Type II collagen and vitamin D receptor 
polymorphism might be associated with risk of 
osteoarthritis in patients with DDH 
 
Locus on chromosome 16p linked to early osteoarthritis 
of the hip 
 
Premature (Beukes) degenerative osteoarthritis of the hip 
mapped to 11 cM region on chromosome 4q35 
 
DDH = developmental dysplasia of the hip; CDH = congenital dislocation of the hip; SNP = single nucleotide polymorphism.
Table 2: This table shows details of radiographic evaluation that was performed on 454 
members of the affected family. The diagnosis of developmental dysplasia of the hip was 455 
made based on these measurements. Affected members of this family are highlighted. 456 
Abbreviations: SL = Shenton’s line, CEA= center edge angle, T = Tonnis, EI = extrusion 457 
index, AC = anterior acetabular coverage, PC = posterior acetabular coverage, FNA = 458 
femoral neck angle, D = disrupted, ND = non-disrupted. 459 
 460 
 
 
 
Shenton’s Line 
(SL) 
Center Edge 
Angle (CEA) 
Tonnis (T) 
(degrees) 
Extrusion Index 
(EI) (mm) 
Anterior 
Acetabular 
Coverage (AC) 
Posterior 
Acetabular 
Coverage (PC) 
Femoral Neck 
Angle (FNA) 
 
 
Family 
member 
 
 
 
Age 
(years) 
 
Left Right 
 
Left Right 
 
Left Right 
 
Left Right 
 
Left Right 
 
Left Right 
 
Left Right 
001 39               
009 11 D* D 12° 18° 24° 24° 16 16 n/a n/a n/a n/a 140° 150° 
011 42 D ND** 3° 6° 20° 24° 28 28 15% 10% 40% 20% 142° 146° 
004 6 ND ND 25° 25° 8° 12° 14 15 20% 30% 70% 50% 134° 132° 
005 18 ND ND 25° 26° 12° 12° 16 16 n/a n/a n/a n/a 136° 136° 
006 41 ND ND 32° 28° 12° 12° 18 18 30% 30% 60% 70% 130° 126° 
008 13 ND ND 28° 32° 10° 6° 14 14 n/a n/a n/a n/a 154° 148° 
014 64 ND ND 18° 22° 0° 0° 14 18 20% n/a 80% 60% 133° 134° 
007 28 ND ND 24° 22° 12° 10° 14 16 20% 30% 70% 50% 144° 144° 
008 13 ND ND 28° 32° 10° 6° 14 14 n/a n/a n/a n/a 154° 148° 
010 n/a ND ND 26° 22° 5° 5° 16 18 n/a n/a n/a n/a 155° 165° 
002 45 ND ND 26° 26° 8° 16° 10 10 20% 20% 80% 80% 138° 134° 
012 49 ND ND 17° 24° 0° 0° 3 3 15% 20% 70% 80% 132° 130° 
013 n/a ND ND 22° 22° 22° 16° 5 6 n/a n/a n/a n/a 132° 130° 
003 49 ND ND 22° 20° 14° 16° 10 10 30% 20% 70% 70% 124° 124° 
016 61 n/a ND 32° 30° 0° 2° 6 6 30% 30% 70% 70% 126° 130° 
 
020 66 ND ND 32° 32° 12° 9° 12 12 20% 20% 60% 60% 138° 142° 
*Disrupted 
**Non-disrupted  
 461 
 462 
 463 
 464 
Table 3: This table demonstrates data on mean, standard deviation and range of normal 465 
values of radiographic measurements. 466 
 Mean SD Range 
Center edge angle (CEA)  23.5° 7.8° 0° - 44° 
Tonnis (T) (degrees) 10.8° 7.6° -7°-32° 
Extrusion index (EI) (mm) 8.4 2.6 2-15 
Femoral neck angle (FNA)  137.3° 9.0° 110°-154° 
 467 
Table 4: This table shows genetic penetrance classes used to analyze affected family. 468 
  469 
Liability 
class 
Individuals in 
each class 
Homozygous for 
normal allele 
Heterozygous Homozygous for 
mutated allele 
1 1,9,11 0 0.8 0.8 
2 4,5,6,8,13,14 0.001 0.8 0.8 
 470 
